Today in the Market (1/23/2024)

Good Morning! On Tuesday, the S&P 500 continued its surge to reach new record levels as investors are now paying close attention to daily earnings reports, seeking valuable information about the overall condition of corporate America and the economy.

The S&P 500 and NASDAQ saw gains of 0.29% & 0.43%, while the Dow Jones spent the day in the red and finished under by 0.25%.

ENDING 2023 ON A GOOD NOTE!

It’s earning season once again and to start us off, we have Netflix (NFLX) with fourth-quarter subscriber additions increasing significantly, surpassing its own projected figures. Not only that, it sent the stock up over 8% in after-hours trading!

  • Revenue: $8.83 Billion vs. $8.71 Billion Expected
  • Subscriber Additions: 13.12 Million vs. 9 Million Expected
  • Earnings per Share: $2.11 vs. $2.20 Expected

So what helped the company? According to the earnings statement, the firm saw a roughly 70% rise in ad-tier subscriptions compared to the previous quarter. With that, the current advertising strategy currently represents 40% of all new subscriptions to Netflix in the regions where it is available. Also, we cannot forget the income strategies such as intensifying efforts to combat password sharing, introducing an ad-supported subscription option, and recently increasing prices for certain membership plans.

Don’t get too comfy, though! Netflix acknowledged that the rivalry remains intense, emphasizing the need to enhance their entertainment offerings. While many rivals are reducing their expenditures on content, Netflix is committed to investing in its lineup.

 

MALARIA VACCINE!

The very recently developed Mosquirix vaccine for malaria, created by GlaxoSmithKline and supported by the World Health Organization (WHO), is currently being administered free of charge to infants aged six months or younger at healthcare centers in Cameroon. According to UNICEF, malaria was responsible for 12% of all childhood fatalities in the nation in 2021.

The good and the bad… Over 600,000 people die each year from malaria, a mosquito-transmitted disease, with Africa accounting for 95% of these fatalities. The vaccination is anticipated to save tens of thousands of lives, yet… The four-dose vaccine is recommended only for children aged up to 17 months. According to health experts, the vaccine has an efficacy rate of around 30% and its effectiveness diminishes after a few months. Additionally, it does not prevent the transmission of the disease so those who have been injected should continue to utilize conventional preventative strategies such as bed nets.

What’s the plan going forward? According to Time, Cameroon aims to immunize around 250,000 children by the end of next year. On top of that, another nineteen African nations plan to begin vaccination programs this year, resulting in an excessive demand that Mosquirix would be unable to meet. However, a second malaria vaccine, recently approved by the WHO, is anticipated to be introduced this year, easing worries about the availability of the vaccine.

 

Scroll to Top

Where Are You On Your Investment Journey?

Rise

Run

Relax

All investors are unique.  The above characteristics are examples, but may not reflect your particular investor demographics or situation.  An advisor with Edgar Investment Management, LLC will assist you with finding the best type of account for you. 

Investment advisory services are offered through Edgar Investment Management, LLC, an investment advisor registered with the State of Texas. Edgar Investment Management, LLC only offers investment advisory services where it is appropriately registered or exempt from registration and only after clients have entered into an investment advisory agreement confirming the terms of engagement and have been provided a copy of the firm’s ADV Part 2A brochure document.

The content found on this website is developed from sources we believe provide accurate information and is for educational purposes only. The information on this website is not intended as tax or legal advice. Everyone’s tax and legal situation is different, so please consult trusted and knowledgeable legal or tax professionals for specific information regarding your individual situation. The opinions expressed and material provided on this website are for general information, and should not be considered a solicitation for the purchase or sale of any security.

Material and information found on this website is not intended as an offer or solicitation for the sale or purchase of any specific security, mutual fund, ETF, bond, or investment strategy.  

Investing is risky!  No guarantee as to performance of any investment is implied by this website.  Make sure you have evaluated your options and spoken with trained professionals before you implement any investment strategy.  Past performance is not indicative of future results.  

Please be advised that Edgar Investment Management, LLC is a financial advisory firm specializing in investment management and financial planning services. We do not offer or provide any CPA-related services, including tax preparation, tax planning, or other accounting services. If you require assistance with tax-related matters, we recommend consulting a qualified CPA or tax professional who can provide specialized advice tailored to your individual needs.

Edgar Investment Management, LLC is not a Public Accounting firm.

 

Contact Us

Name
Best time(s) to contact you?
Best method(s) to contact you?

Contact Us

Name
Best time(s) to contact you?
Best method(s) to contact you?

We would love to hear from you! Please fill out this form and we will get in touch with you shortly.

  • About You

    Tell us a little about yourself. Don't be shy. Let's be friends.
  • How Can We Reach You?

    We would love to chat with you. How can we get in touch with you?
  • What's on your mind?

How much do you want to invest?